Keith W. Marshall
2021 - Prometheus Biosciences
In 2021, Keith W. Marshall earned a total compensation of $4.1M as Chief Financial Officer and Treasurer at Prometheus Biosciences, a 438% increase compared to previous year.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $340,000 |
| Option Awards | $3,132,618 |
| Salary | $418,681 |
| Other | $12,986 |
| Total | $4,104,285 |
Marshall received $3.1M in option awards, accounting for 76% of the total pay in 2021.
Marshall also received $200K in bonus, $340K in non-equity incentive plan, $418.7K in salary and $13K in other compensation.
Rankings
In 2021, Keith W. Marshall's compensation ranked 3,263rd out of 12,415 executives tracked by ExecPay. In other words, Marshall earned more than 73.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,263 out of 12,415 | 74th |
Division Manufacturing | 1,323 out of 5,505 | 76th |
Major group Chemicals And Allied Products | 537 out of 2,375 | 77th |
Industry group Drugs | 477 out of 2,096 | 77th |
Industry Pharmaceutical Preparations | 330 out of 1,546 | 79th |
Source: SEC filing on April 1, 2022.
Marshall's colleagues
We found three more compensation records of executives who worked with Keith W. Marshall at Prometheus Biosciences in 2021.